102 related articles for article (PubMed ID: 8407547)
1. Suppression of rabbit VX-2 subcutaneous tumor growth by gadolinium neutron capture therapy.
Akine Y; Tokita N; Tokuuye K; Satoh M; Churei H; Le Pechoux C; Kobayashi T; Kanda K
Jpn J Cancer Res; 1993 Aug; 84(8):841-3. PubMed ID: 8407547
[TBL] [Abstract][Full Text] [Related]
2. The effect of intra-articular gadolinium-DTPA on synovial membrane and cartilage.
Hajek PC; Sartoris DJ; Gylys-Morin V; Haghighi P; Engel A; Kramer F; Neumann CH; Resnick D
Invest Radiol; 1990 Feb; 25(2):179-83. PubMed ID: 2312253
[TBL] [Abstract][Full Text] [Related]
3. Electron-equivalent dose for the effect of gadolinium neutron capture therapy on the growth of subcutaneously-inoculated Ehrlich tumor cells in mice.
Akine Y; Tokita N; Tokuuye K; Satoh M; Kobayashi T; Kanda K
Jpn J Clin Oncol; 1993 Jun; 23(3):145-8. PubMed ID: 8350487
[TBL] [Abstract][Full Text] [Related]
4. Detection of hepatocellular carcinoma with dynamic MR imaging during intraarterial infusion of gadopentetate dimeglumine.
Fujita T; Ito K; Choji T; Honjo K; Matsumoto T; Arita T; Nakanishi T
AJR Am J Roentgenol; 1994 Oct; 163(4):865-6. PubMed ID: 8092025
[No Abstract] [Full Text] [Related]
5. Hemodynamic effects of gadodiamide injection and gadopentetate dimeglumine in anesthetized dogs.
Peters JL; Shaw DD
Acta Radiol; 1993 Sep; 34(5):510-6. PubMed ID: 8369191
[TBL] [Abstract][Full Text] [Related]
6. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
Campos A; Aznar L; Alamar R; Castelló JV
Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
[No Abstract] [Full Text] [Related]
7. In vivo gadolinium neutron capture therapy using a potentially effective compound (Gd-BOPTA).
Matsumura A; Zhang T; Yamamoto T; Yoshida F; Sakurai Y; Shimojo N; Nose T
Anticancer Res; 2003; 23(3B):2451-6. PubMed ID: 12894527
[TBL] [Abstract][Full Text] [Related]
8. Gadolinium as a neutron capture therapy agent.
Shih JL; Brugger RM
Med Phys; 1992; 19(3):733-44. PubMed ID: 1508113
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of cardiodepressive effects of gadopentetate dimeglumine with addition of ionic calcium.
Mühler A; Saeed M; Brasch RC; Higgins CB
Radiology; 1992 Jul; 184(1):159-64. PubMed ID: 1609076
[TBL] [Abstract][Full Text] [Related]
10. Sonographic guidance of needle position for MR arthrography of the shoulder.
Valls R; Melloni P
AJR Am J Roentgenol; 1997 Sep; 169(3):845-7. PubMed ID: 9275909
[No Abstract] [Full Text] [Related]
11. Gadolinium neutron capture therapy (GdNCT) of melanoma cells and solid tumors with the magnetic resonance imaging contrast agent Gadobutrol.
Hofmann B; Fischer CO; Lawaczeck R; Platzek J; Semmler W
Invest Radiol; 1999 Feb; 34(2):126-33. PubMed ID: 9951792
[TBL] [Abstract][Full Text] [Related]
12. Approval from the Food and Drug Administration for unapproved use of an approved drug or device.
Bates BF
AJR Am J Roentgenol; 1994 Sep; 163(3):748; author reply 748-9. PubMed ID: 8079894
[No Abstract] [Full Text] [Related]
13. In vivo evaluation of neutron capture therapy effectivity using calcium phosphate-based nanoparticles as Gd-DTPA delivery agent.
Dewi N; Mi P; Yanagie H; Sakurai Y; Morishita Y; Yanagawa M; Nakagawa T; Shinohara A; Matsukawa T; Yokoyama K; Cabral H; Suzuki M; Sakurai Y; Tanaka H; Ono K; Nishiyama N; Kataoka K; Takahashi H
J Cancer Res Clin Oncol; 2016 Apr; 142(4):767-75. PubMed ID: 26650198
[TBL] [Abstract][Full Text] [Related]
14. Design and preparation of ethyl cellulose microcapsules of gadopentetate dimeglumine for neutron-capture therapy using the Wurster process.
Fukumori Y; Ichikawa H; Tokumitsu H; Miyamoto M; Jono K; Kanamori R; Akine Y; Tokita N
Chem Pharm Bull (Tokyo); 1993 Jun; 41(6):1144-8. PubMed ID: 8370113
[TBL] [Abstract][Full Text] [Related]
15. Effect on fetal mouse development of exposure to MR imaging and gadopentetate dimeglumine.
Rofsky NM; Pizzarello DJ; Weinreb JC; Ambrosino MM; Rosenberg C
J Magn Reson Imaging; 1994; 4(6):805-7. PubMed ID: 7865940
[TBL] [Abstract][Full Text] [Related]
16. In vivo target-specific delivery of macromolecular agents with MR-guided focused ultrasound.
Bednarski MD; Lee JW; Callstrom MR; Li KC
Radiology; 1997 Jul; 204(1):263-8. PubMed ID: 9205257
[TBL] [Abstract][Full Text] [Related]
17. MR diagnosis of head and neck tumors: comparison of contrast enhancement with triple-dose gadodiamide and standard-dose gadopentetate dimeglumine in the same patients.
Vogl TJ; Mack MG; Juergens M; Stark M; Pegios W; Bergman C; Grevers G; Western A
AJR Am J Roentgenol; 1994 Aug; 163(2):425-32. PubMed ID: 8037044
[TBL] [Abstract][Full Text] [Related]
18. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
Low RN; Francis IR
AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
[TBL] [Abstract][Full Text] [Related]
19. [MRT of experimental liver abscesses: a comparison of a new blood pool contrast medium with gadolinium-DTPA in animal experiments].
Dick A; Adam G; Spüntrup E; Prescher A; Mühler A; Günther RW
Rofo; 1996 Oct; 165(4):392-7. PubMed ID: 8963054
[TBL] [Abstract][Full Text] [Related]
20. Are gadolinium contrast agents suitable for gadolinium neutron capture therapy?
De Stasio G; Rajesh D; Casalbore P; Daniels MJ; Erhardt RJ; Frazer BH; Wiese LM; Richter KL; Sonderegger BR; Gilbert B; Schaub S; Cannara RJ; Crawford JF; Gilles MK; Tyliszczak T; Fowler JF; Larocca LM; Howard SP; Mercanti D; Mehta MP; Pallini R
Neurol Res; 2005 Jun; 27(4):387-98. PubMed ID: 15949236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
